About Nicolas Mosimann

Nicolas Mosimann shares his clients’ passion for innovation, entrepreneurship and swift solutions to complex challenges. Nicolas co-heads the Kellerhals Carrard Start-up and Venture Capital Desk and the Life Sciences practice group and has in-depth experience with the start-up ecosystem and the entire life cycle of biotech, pharmaceutical, medtech and healthtech companies, including financing rounds, exits, listings, M&A transactions and licensing deals. As external general counsel of MoonLake Immunotherapeutics’ (Nasdaq: MLTX), Nicolas has gained a profound understanding of the needs of a biotech company and the life sciences industry.